Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Takeda Ventures, Inc.

Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
  • United Kingdom
Investment stages
  • Seed
Industries
  • Tech
About
Takeda Ventures, Inc. is the corporate venture Capital group of Takeda, founded in 2001, with a vision to generate disruptive technologies and therapeutic solutions through venturebased investments. They partner with academic innovators, entrepreneurs, and venture investors to create and nurture a portfolio of companies aligned with Takedažs R&D pillars, such as Oncology, Rare Genetics & Hematology, Neuroscience, and Gastrointestinal and Inflammation.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

Takeda Ventures focuses on highcaliber, therapeutic, platformbased companies around the world. It specifically invests in early stage, preclinical opportunities and products which complement Takedažs pipeline with the mission to create strategic growth opportunities for Takeda through building, managing, and investing in innovative companies.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp